G6PD and malignant colon neoplasm: On the other hand, the G6PD was used to explain BPA-mediated diseases in colon cancer cells (SW480), mammary glands, and Sertoli cells because the G6PD was accepted as one of the sensitive biomarkers and can be used for the prediction of BPA-mediated diseases (Ryu et al., 2017).